Monday Motivation: 'Entrepreneurship is about staying the course'
Lupin to bet big on biosimilar sales in mid term, ramp capacity expansion
We Can Go Up To Rs 20,000 Cr When It Comes To Acquisitions: Lupin Global CFO
Tariffs may raise US drug prices; manufacturing shift not easy: Lupin global CFO
Senior General Manager and Centre Head, Atharv Ability, Dr Gaurish Kenkre's authored article on 'From bed to walking: How rehabilitation helps accident survivors rebuild strength, confidence and independence after serious injuries' published in The Times of India, Mumbai edition
Yashwant Mahadik featured in an industry story titled 'Experts say that not every star employee should become a manager' in the ET HRWorld
Ramesh Swaminathan featured in an industry story on 'Tariffs may raise US drug prices; manufacturing shift not easy' published by The Financial Express
Christoph Funke featured in an industry story by BioSpectrum India (print) on 'Digital Bioprocessing Tools Powering Indian Pharma.
Ramesh Swaminathan and Rajeev Sibal featured in a story published by Business Today on Lupin's evolving GLP-1 and weight-loss drug strategy.
Rakesh Bhardwaj in conversation with Analytics India Magazine (AIM). Topic 'How Pharma Navigates AI Adoption'
Expert inputs by Dr Monika Shashank, Head of Operations, Lupin Diagnostics on 'Why waiting for symptoms could be the biggest mistake women make about their health' featured in The Times of India
Vinita Gupta, Nilesh Gupta, Ramesh Swaminathan with ET Now, Q4 FY26 Earnings, 8th May 2026
Ramesh Swaminathan with NDTV Profit, Q4 FY26 Earnings, 8th May 2026
Insights from the leading minds in our industry
Vice President and Global Head – Corporate Communications
